Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits
AL-SIGHT
Using Telemedicine to Prevent Blindness in an At-risk Rural Alabama Population
3 other identifiers
interventional
900
1 country
1
Brief Summary
Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2020
CompletedFirst Posted
Study publicly available on registry
March 31, 2020
CompletedStudy Start
First participant enrolled
November 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedResults Posted
Study results publicly available
July 25, 2025
CompletedAugust 7, 2025
July 1, 2025
3.6 years
March 27, 2020
June 18, 2025
July 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Participants That Adhere to Referral Appointment
The percentage of patients who adhere to attending their referral appointments who received a financial incentive and eye health education will be compared with the percentage of patients who adhere to attending their referral appointments who received standard of care eye health education alone and no financial incentive for completing a referral visit.
The time frame will be whether they attended the referral appointment between the screening date until 6 months after the screening date.
Study Arms (2)
No financial incentive
OTHERThis group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.
Financial incentive
EXPERIMENTALThis group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.
Interventions
Standard of care eye health education
Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
Eligibility Criteria
You may qualify if:
- African American or Hispanic ≥40 years
- Non-Hispanic white ≥50 years
- Anyone ≥ 18 years with diabetes
- Anyone ≥ 18 years with a glaucoma associated diagnosis
- Anyone ≥ 18 years with a family history of glaucoma
- All enrollees must be able to speak and understand English
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Related Publications (1)
Rhodes LA, Register S, Asif I, McGwin G Jr, Saaddine J, Nghiem VTH, Owsley C, Girkin CA. Alabama Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (AL-SIGHT): Study Design and Methodology. J Glaucoma. 2021 May 1;30(5):371-379. doi: 10.1097/IJG.0000000000001794.
PMID: 33492893DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Cynthia Owsley
- Organization
- University of Alabama at Birmingham
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher A Girkin, MD, MSPH
University of Alabama at Birmingham
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The investigators are masked as to which group the patient is in.
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 27, 2020
First Posted
March 31, 2020
Study Start
November 18, 2020
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
August 7, 2025
Results First Posted
July 25, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
To be determined at a later point.